Walleye Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.44M Buy
7,000
+100
+1% +$101K 0.03% 638
2025
Q4
$7.42M Sell
6,900
-12,300
-64% -$11.8M 0.02% 852
2025
Q3
$14.6M Sell
19,200
-5,700
-23% -$4.24M 0.06% 375
2025
Q2
$19.4M Buy
24,900
+18,300
+277% +$14.2M 0.08% 245
2025
Q1
$5.45M Sell
6,600
-33,600
-84% -$28M 0.02% 730
2024
Q4
$31M Sell
40,200
-5,500
-12% -$4.55M 0.08% 206
2024
Q3
$40.5M Sell
45,700
-4,000
-8% -$3.6M 0.08% 151
2024
Q2
$45M Sell
49,700
-8,900
-15% -$7.12M 0.08% 146
2024
Q1
$45.6M Sell
58,600
-11,600
-17% -$8.26M 0.08% 160
2023
Q4
$40.9M Sell
70,200
-5,900
-8% -$3.44M 0.09% 137
2023
Q3
$40.9M Buy
76,100
+26,200
+53% +$13.5M 0.1% 99
2023
Q2
$23.4M Buy
49,900
+44,100
+760% +$18.5M 0.08% 129
2023
Q1
$1.99M Sell
5,800
-400
-6% -$135K 0.03% 730
2022
Q4
$2.27M Sell
6,200
-2,000
-24% -$709K 0.04% 521
2022
Q3
$2.65M Buy
+8,200
New +$2.6M 0.05% 427
2020
Q2
Sell
-8,500
Closed -$1.18M 809
2020
Q1
$1.18M Sell
8,500
-33,900
-80% -$4.66M 0.26% 108
2019
Q4
$5.57M Sell
42,400
-74,500
-64% -$8.64M 0.36% 35
2019
Q3
$13.1M Buy
116,900
+77,000
+193% +$8.57M 0.78% 5
2019
Q2
$4.42M Buy
39,900
+33,400
+514% +$3.93M 0.49% 16
2019
Q1
$843K Buy
+6,500
New +$790K 0.14% 218

Other funds holding LLY

Walleye Capital's LLY Position: Q1 2026 in Review

Walleye Capital reduced its Eli Lilly (LLY) stake by 43% in Q1 2026, selling an estimated $15.7M and leaving 20,644 shares worth $19M. The position accounts for 0.08% of the portfolio, ranked #210.

Walleye Capital first reported a position in LLY in Q1 2019 and has held it in 22 quarters since. The position peaked at $47M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Walleye Capital held 20,644 shares of Eli Lilly worth $19M as of Q1 2026.
  • Walleye Capital sold 15,497 Eli Lilly shares in Q1 2026, an estimated $15.7M.
  • Eli Lilly made up 0.08% of Walleye Capital's portfolio in Q1 2026, its #210 holding.
  • Walleye Capital first reported a position in Eli Lilly in Q1 2019 and has held it in 22 quarters since.
  • Walleye Capital's Eli Lilly position peaked at $47M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.